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The failure of central nervous system axons to regenerate is a known consequence 
of traumatic injury and neurodegenerative disease. The central nervous system’s 
regenerative capacity starkly contrasts with the peripheral nervous system, which 
demonstrates robust regeneration following injury. This ability is due to factors both 
extrinsic and intrinsic to the cell. Extrinsically, the environment of the central 
nervous system is inhospitable, presenting both physical and chemical barriers to 
regeneration. However, extrinsic factors are not the only component. When placed 
in a peripheral nervous context, central nervous system neurons still show only 
modest gains in regeneration. Intrinsically, the peripheral nervous system is able 
to upregulate genes known as regeneration associated genes which are important 
for the system’s ability to regenerate. These genes, when expressed in a central 
nervous system neuron can promote gains in regeneration, although not to the 
same extent as the peripheral nervous system.  
 
Despite an identical genetic complement, the central nervous system is unable to 
independently mobilize regeneration associated genes and promote regeneration. 
For this reason, we hypothesized that epigenetic differences between the central 
and peripheral nervous systems may be responsible. These epigenetic signatures 
are acquired by cells as they mature and differentiate. DNA methylation and 
chromatin structure are positioned so as to protect cell identity and allow 
expression of genes necessary for that cell’s function. Adult neurons must be 
tightly regulated. As such, many genes responsible for the growth and 
 iii 
regeneration abilities seen in embryonic neurons are epigenetically silenced once 
the cell is fully differentiated.  
 
We show that Tet3, a DNA demethylase, is essential for regeneration in the PNS. 
In our model, Tet3 activates a suite of regeneration association genes necessary 
to initiate the regeneration program in the peripheral nervous system. Tet3 
accomplishes this by selectively demethylating key regions of essential 
regeneration associated genes and allowing their expression. Without Tet3, the 
cell is unable to achieve functional regeneration. 
 
This study highlights the precise and delicate nature of regeneration in the 
peripheral nervous system and underscores the need for a holistic approach to 
activating regeneration in the central nervous system. Future studies will need to 
further refine the role of these dual highly regulated processes, transcription and 
translation, to unlock the regenerative potential of the central nervous system.  
 
Thesis Advisor: Dr. Hongjun Song 
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CHAPTER 1 - INTRODUCTION 
1.1 Nervous system injury and disease 
The central nervous system (CNS), composed of the brain, optic nerve, and spinal 
cord, is unable to regenerate. This failure contributes greatly to CNS morbidity and 
mortality. When insult occurs to a CNS neuron, such as in the case of stroke, injury, 
or neurodegenerative disease, the system is unable to repair the damage and the 
neuron dies [1]. Because the CNS is largely composed of post-mitotic neurons 
without a stem cell reservoir, lost neurons cannot be replaced. Thus, injury and 
disease lead to loss of normal CNS function [2]. In stark contrast, the peripheral 
nervous system (PNS) has robust, sustained regeneration. Although many 
inherent differences exist between the CNS and the PNS, much can be gained 
from a deeper understanding of the PNS’s regenerative program.  
 
1.2 Wallerian degeneration 
Soon after axonal injury, in both the CNS and PNS, Wallerian degeneration (WD) 
is activated [3]. In this process, the molecular components of injured axons are 
systematically disassembled and myelin is broken down, generating debris [4]. 
Although the location and timing of WD varies slightly according to the organism 
and type of injury, the general process is rapid and is conserved across vertebrates 
[4, 5]. Importantly, these debris will prevent new axonal growth if not properly 




1.3 Extrinsic barriers to regeneration  
The debris generated by WD secrete inhibitory proteins that produce sustained 
inhibition of regeneration [7, 8].  These proteins, generally produced from the 
breakdown of myelin, include: NogoA, myelin-associated glycoprotein, and others 
[9-11]. Although inhibitory proteins are present in both the central and peripheral 
nervous systems, the PNS is able to clear the debris [12]. In the PNS, 
macrophages and other phagocytic cells gather to clear the myelin sheath and 
other debris resulting from degeneration [13]. This occurs rapidly in the PNS. In 
mice, the initial clearance phase in the PNS takes around 72 hours and is complete 
in 1-2 weeks [14]. Conversely, this process is very slow in the CNS and it can take 
years to fully clear the debris [3, 14]. Further, the CNS forms a glial scar made up 
of reactive astrocytes, cytoskeletal elements, and other debris. Although helpful 
for stabilization of the CNS after injury, this scar presents a physical barrier across 
which regenerating axons cannot grow [15, 16]. 
 
Slow axon clearance is one of the main extrinsic limitations of the CNS. The 
sustained presence of regeneration inhibitors is prohibitive for regeneration. In the 
newt, which exhibits robust axonal regeneration, even in the CNS, the phagocytic-
immune response to CNS injury is as rapid as the mammalian response to PNS 
injury [17]. This rapid immune response clears the way for regeneration of the 
injured CNS axons. This point is further illustrated by transplantation experiments. 
First, when PNS neurons are exposed to the CNS environment, reactive 
oligodendrocytes, the myelinating cells of the CNS, induce rapid, sustained loss of 
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neurite outgrowth potential [18]. Schwann cell transplants, the myelinating cell of 
the PNS, are sufficient to significantly increase axonal regeneration of CNS 
neurons [19-21]. Further, Schwann cell grafts can remyelinate axons, restoring 
conductive communication in the CNS [22].  
 
These experiments, taken together, suggest that the external environment is an 
essential part of the regenerative mechanism of the PNS. However, transplantation 
experiments have shown that most CNS neurons are unable to regenerate, even 
in the permissive context of the PNS. Those that do, are unable to reach the full 
functional recovery seen in the PNS [20, 21, 23]. Clearly, intrinsic factors are also 
an important component of regeneration.  
 
1.4 Intrinsic programs of regeneration  
Although there is diversity in response to injury amongst neurons, PNS and CNS 
neurons generally respond very differently to injury. First, in the neuronal cell body 
of both systems, injury triggers swelling, displacement of the nucleus, localization 
of the Nissl substance, and loss of synaptic function. Regeneration-competent 
PNS neurons become hypertrophic and upregulate overall metabolism, including 
protein translation, while regeneration-noncompetent CNS neurons either display 
no obvious physiological reaction, or decrease in volume and reduce dendritic 
number [24-26]. In the PNS, injury signals a change in intracellular ion 
concentrations and propagates a retrograde calcium wave from the point of injury 
to the cell body [27]. This signal, which propagates at 1mm/minute in rodents, is 
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responsible for the upregulation of protein translation and the reorganization of the 
cytoskeleton, as discussed above. In addition, the calcium wave signals formation 
of a growth cone-like structure, a component initially seen during development and 
which is essential to axon extension [28-30]. This structure forms within 24 hours 
and regrowth begins soon after [31, 32]. In contrast, the injured ends of many CNS 
axons retract and form a dystrophic bulb that is prohibitive for regeneration, even 
in the face of a regeneration-permissive environment [32, 33]. 
 
1.5 Regeneration associated genes  
Essential to the success of the peripheral response is the activation of a genetic 
pro-regenerative program, known to involve de novo transcription of genes 
silenced in the basal state [34]. Genes that are transcribed in this manner, 
essential for PNS regeneration, are commonly known as RAGs (regeneration 
associated genes). The first genes identified from this group, the GAP family 
(including GAP-43), was found to have little expression in the injured CNS but 
robust upregulation in the PNS following injury, and to be essential to regeneration 
[35]. To date, the list of annotated, experimentally confirmed RAGs has grown to 
over 300 [36]. Each gene added to the list generally follows the same framework 
as described above and, in addition, may also induce CNS regeneration through 
overexpression of the RAG (for examples, see: [37-39]). Many RAGs are 
transcription factors and therefore orchestrate a larger genetic transcription 
response [38]. For this reason, work in the field has focused on closely 
approximating the complete transcription program elicited in the PNS [36]. For 
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example, knockout (KO) of KLF4, a transcription factor with numerous targets, was 
found to increase regeneration in the optic nerve [40]. Generally, however, any 
genetic manipulation has focused on the modification of only a handful of genes 
[41-43]. 
 
Together, these studies make it clear that regeneration in the peripheral nervous 
system requires a concerted, global, and sustained change that regulates activities 
as diverse as microtubule reorganization and de novo gene transcription. This 
suggests two things: first, that the peripheral nervous system might be a good 
starting place for unraveling the problem of regeneration in all neuronal systems; 









CHAPTER 2 - Epigenetic regulation of regeneration 
2.1 Introduction 
The epigenome is a dynamic system. Epigenetic molecular changes, which can 
be heritable, regulate transcription without altering the genetic code itself [44].  
Generally, these changes are divided into two categories: DNA methylation and 
histone modifications. In addition to other regulatory proteins, such as the 
SWI/SNF remodeling complex, these mechanisms regulate gene transcription.  
  
2.2 Chromatin and histone modifications 
DNA is organized in a hierarchical manner, packaged to be read and interpreted 
appropriately for the cell’s needs. During normal cellular activity, the 2nm DNA 
helix is wrapped around nucleosomes to form the 10nm ‘beads-on-a-string’ 
structure. The DNA is organized for active use or inactive storage with additional 
proteins, such as the linker H1 protein [45]. Nucleosomes are made up of an octet 
of histones, two copies each of H2A, H2B, H3, and H4. Each of these histones has 
an N and C-terminal tail whose amino acid residues, such as arginine and lysine, 
can be modified to alter the chromatin structure, and thus the level of transcription 
[46].  
 
These modifications can either condense DNA into transcriptionally inaccessible 
heterochromatin or transcriptionally active euchromatin. The cell interprets the 
pattern of histone modifications and makes appropriate changes. This histone 
modification pattern, called ‘the histone code’, is complex and still not well 
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understood [47]. However, in general, histone methylation silences transcription 
while histone acetylation produces active transcription [48].  
 
2.3 DNA methylation 
Like histones, the DNA itself can also be modified to alter transcription [49]. A 
methyl group can be added to cytosine, generally in, but not exclusively limited to, 
CpG sites [50, 51]. This covalent modification of the 5-carbon position of cytosine 
produces 5-methylcytosine (5mC). Methylated cytosine presents a physical 
impediment to the binding of the transcription machinery and interacts in a 
cooperative manner with histone modifications to coordinate transcriptional 
changes [52].  
 
2.4 Modifications are dynamic and fundamental 
The epigenetic machinery is made up of ‘writers’, which apply the modifications, 
‘readers’, which interpret the modifications and direct the cell accordingly, and 
‘erasers’, which remove existing modifications. Histone modifications are added by 
a family of histone acetyltransferases (HATs), histone methyltransferases (HMTs), 
and others according to the modification being added. These modifications can be 
removed through a related family of proteins such as histone deacetylases 
(HDACs) and histone demethylases (HDMs), respectively [53]. Readers, an 
equally diverse family of proteins, have modification binding domains which can 
bind directly to and recruit other components, such as the polycomb repressive 
complex and Trithorax active complex, to produce the required regulatory effect 
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[54, 55]. DNA methylation is added by DNA methyltransferases (DNMT) and 
removed by Ten-eleven translocation (TET) enzymes [56, 57]. The family of DNA 
methylation readers is diverse, but all contain a methyl-binding domain [58]. 
 
During development, DNA is selectively and progressively silenced as the cell 
moves along its differentiation path [59]. This tightly controls transcription to a 
situation-appropriate level. This type of epigenetic activity is generally considered 
to be stagnant, changing in only very limited cases, particularly in regards to post-
mitotic cells [60]. However, the moment-to-moment needs of a cell change 
drastically, and the dynamic nature of the epigenome is equipped to handle these 
changes in transcriptional demand. DNA methylation was originally hypothesized 
to regulate gene expression as early as the 1970s, but was thought to be removed 
passively, through cell division. However, it was recently discovered that 
methylation can be selectively targeted and removed through iterative oxidation 
followed by base excision repair [57, 61, 62]. Similarly, histone modifications can 
be removed quickly and efficiently [63]. The dynamic nature of the epigenome is 
an important component of cellular plasticity and is essential for responding to 
environmental changes, such as injury.   
 
2.5 Neuroepigenetics 
The regulation of large transcriptional programs is essential for the normal function 
of many systems (for example see: [64]). The tight regulation of the epigenome is 
particularly relevant for neurons, post-mitotic cells which must respond delicately 
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to insult [65]. Unsurprisingly, there is a significant epigenetic contribution to the 
neural transcriptome landscape [66]. Developing neurons have a significantly 
different transcriptional load than mature neurons. 5-hydroxymethylcytosine 
(5hmC), an oxidative product of 5mC, tends to increase as development 
progresses and decrease during dedifferentiation [67, 68]. As the cell develops, 
transcriptional programs associated with growth and differentiation are silenced 
and, in the CNS, intrinsic growth capacity declines [60, 69, 70]. This tight regulation 
is essential to proper growth and development. For example, a mutation in any of 
the three DNMTs is incompatible with life [71, 72]. Scenarios in which the mutation 
only occurs in a neuronal system still have profound consequences on proper 
neural development [73]. In mature neurons, transcription is also regulated by 
epigenetics. For example: growth arrest and DNA-damage-inducible protein 45β 
(GADD45β) promotes adult hippocampal neurogenesis [74]. Changes in the 
epigenome are essential to neural plasticity, such as in learning and memory 
formation or in acute activation of neural pathways [75, 76]. 
 
2.6 Histone acetylation and regeneration 
Several recent studies reveal the specific role of histone modifications in 
regeneration. First, overexpression of the acetyltransferase p300 increases CNS 
regeneration [77]. This connects the high demand of newly synthesized RNAs with 
the role of histone acetylation in the activation of gene transcription [34, 48]. Next, 
nuclear export of HDAC5 (a histone deacetylase) is essential for the accumulation 
of acetylation in the PNS after injury. If HDAC5 is modified and prevented from 
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exiting the nucleus, regeneration cannot proceed [78]. Further, histone H4 is 
hypoacetlylated in the CNS. Pharmaceutical-facilitated acetylation accumulation 
also increases regeneration in the CNS [79]. These studies highlight the role of 
activating histone marks in regeneration. However, histone modifications are only 
one component of the epigenetic machinery. Modification of DNA demethylation 
also allows the upregulation of genes through the removal of repressive 
methylation [57, 80].  
 
PNS regeneration requires complete transcriptional reprogramming to meet the 
demands of the injured neuron. The epigenome, as a dynamic, crucial regulatory 
system is equipped to meet these needs. In this study, we investigate the role of 





CHAPTER 3 - RESULTS 
3.1 Dorsal Root Ganglion 
The peripheral nervous system demonstrates robust, sustained regeneration after 
injury. Therefore, we chose to use this system to investigate the role of DNA 
methylation in injury response. The dorsal root ganglion (DRG) is a well-
established model of PNS injury [34]. The DRG is a bundle of sensory neuronal 
nuclei that lies just off of the spinal cord. DRG neurons are pseudo-bipolar. They 
possess two axonal branches, one, which projects distally, reaching the far 
extremities to provide sensory feedback, and one, which projects proximally, 
reaching into the spinal cord. The sciatic nerve, which projects from the L4/L5 
vertebrae in mice, is composed of both motor neurons, whose cell bodies lie inside 
the spinal cord, and sensory neurons from the DRG [81] (Figure 3.1). The sciatic 
nerve is relatively superficial and can be exposed and injured with only minor 
invasion [82]. In this study, we performed a sciatic nerve lesion (SNL) injury via 
crush (Figure 3.2). Molecular analysis was completed in the DRG, and assessment 
of regeneration was completed in the sciatic nerve.  
 
3.2. Demethylation following injury 
First, we first determined whether DNA methylation was involved in injury 
response. We performed SNL surgery on wild type (WT) mice, removed the DRG 
at one day post-SNL (SNL D1), and extracted RNA from the whole DRG. In each 
mouse, we performed SNL on one side, and kept the contralateral side naive as 
an internal control. We used qPCR to screen for known demethylation mediators: 
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Tet1-3, Apobec1-3, Gadd45a, Gadd45b, Gadd45g, and Tdg [83, 84]. Gadd45a, 
Gadd45g, and Tet3 were upregulated following injury (Figure 3.3). Gadd45a has 
previously been shown to regulate DNA demethylation, and can be induced by 
neural activity [74]. The observed upregulation of Gadd45a is consistent with 
previously published data [85].  
 
3.3 Tet3 upregulation 
The Tet family of enzymes consists of 3 members: Tet1, Tet2, and Tet3. Each of 
which can iteratively oxidize 5mC to return it to its unmodified cytosine state 
(Figure 3.4) [84]. Interestingly, Tet3, but not Tet1 or Tet2, is active in the DRG 
(Figure 3.3). This is true at both basal conditions and following injury, despite 
robust expression of all three Tets in the hippocampus (Figure 3.5). Tet3 is induced 
by SNL D1, reaches peak expression level at SNL D3, and has returned to basal 
levels by SNL D14 (Figure 3.6). We further investigated Tet3 expression using in 
situ analysis of DRG cross-sections to identify which cell type accounts for the 
observed transcriptional upregulation in the whole DRG. For this experiment, we 
used a transgenic reporter mouse line that expresses GCaMP3 from the 
endogenous Pirt locus. This line labels over 95% of neurons in the adult DRG [86]. 
Tet3 is neuron specific and its upregulation occurs at both the transcript and 





3.4 Retrograde signaling  
It has been established that the injured axon signals the soma to activate a 
regenerative program via calcium retrograde signaling [87]. For this reason, we 
thought it likely that calcium signaling was involved in Tet3 upregulation. To test 
this, we measured Tet3 levels after treatment with a calcium chelator and a CaMKII 
inhibitor, BAPTA-AM and KN93, respectively. Both inhibitors blocked the 
upregulation of Tet3 in the DRG while KN92, an inactive analog, did not (Figure 
3.9). This is consistent with previously published data on histone modifications and 
regeneration [78]. 
 
3.5 Tet3 KD blocks demethylation 
The demethylation of 5mC is one of the main roles of enzymes in the Tet family 
(Figure 3.4). Therefore, we asked whether the upregulation of Tet led to an 
increase in 5hmC, an oxidative derivative of 5mC (Figure 3.4). 5hmC increases in 
Pirt-GCaMP3+ DRG neurons at SNL D1 (Figure 3.10). Further, the time course of 
5hmC corresponds to the time course of Tet3; 5hmC levels are higher at SNL D1, 
peak at SNL D3, and return to normal by SNL D14 (Figure 3.11). This suggests 
that Tet3 is involved in the global demethylation of 5mC observed following injury.  
 
To determine whether the time course association of 5hmC and Tet3 is correlative 
or causative, we designed an adeno-associated virus (AAV) to target and 
knockdown (KD) expression of Tet. The virus contained both a previously 
characterized small hairpin RNA (shRNA), as well as a GFP reporter [88]. We 
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delivered the virus via intrathecal injection to WT mice (Figure 3.12). By injecting 
between the 4th and 5th lumbar vertebra, the virus can disseminate into the 
corresponding DRG. Both the Tet3 KD (Tet3-shRNA) and control (ctrl-shRNA), 
containing a scrambled shRNA, effectively labeled over 70% of L4/L5 DRG 
neurons (Figure 3.13). Tet3 KD eliminated the SNL-mediated increase in 5hmC, 
suggesting that Tet3 is directly involved in injury-related global demethylation 
(Figure 3.14, 3.15, 3.16).  
 
3.6 RAG expression 
As described above, RAGs are essential for regeneration in the PNS, and, 
therefore any comprehensive pro-regenerative program will likely regulate RAGs 
[34]. We next investigated whether Tet3 upregulation was associated with RAG 
expression in vivo. For this, we compared RAG levels in Tet3-shRNA treated 
animals to RAG levels in ctrl-shRNA treated animals. In the ctrl-shRNA, RAGs had 
low basal expression and upregulation following injury. However, Tet3 KD blocked 
the expression of several RAGs including: ATF3, Smad1, STAT3, and c-Myc [89, 
90](Figure 3.17). Additionally, Tet3 altered the basal expression of some RAGs 
(Figure 3.15). Together, this data presents a model wherein Tet3 regulates 
expression of RAGs both under naive conditions as well as in response to injury. 
 
3.7 ATF3 expression 
In order to interrogate the effect of Tet3 on RAG expression more fully, we chose 
one gene, ATF3, to explore further. ATF3 is one of the most robustly upregulated 
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genes following SNL and has the capacity to increase CNS regeneration [38, 91]. 
Immunohistochemical (IHC) staining of ATF3 in the DRG was consistent with 
previous publications. Importantly however, Tet3 KD attenuated the normal 
upregulation of ATF3 (Figure 3.18). There is little to no ATF3 expression through 
SNL D7, suggesting that Tet3 blocks expression of RAGs rather than delaying their 
expression (Figure 3.18). Finally, retrograde signaling, as assessed though 
quantitative IHC staining of c-jun, is intact (Figure 3.19) [87]. This suggests that 
Tet3 does not block all injury-induced signaling, instead acting in a more precise 
manner.   
 
3.8 RAG demethylation 
Next, we next wanted to determine whether the Tet3-mediated upregulation of 
RAGs occurred via demethylation. Because the DRG is 90% non-neuronal cells, 
we enriched for neurons using a sucrose cushion [92, 93]. First we first screened 
ATF3 for methylated sites using methylation sensitive restriction enzymes (MSRE) 
which can identify 5mC and 5hmC sites within the sequence CCGG [94]. We 
determined that, although the promoter was relatively free of methylation, distal 
enhancer regions were hypermethylated (Figure 3.20). Enhancer regions 
modulate transcription through the binding of various proteins, and are particularly 
important centers for methylation [95]. At SNL D1, several sites, including distal 
enhancer regions, exhibited a decrease in methylation (Figure 3.20). We also 
screened c-Myc, a gene recently shown to be an important RAG whose 
overexpression can lead to gains in CNS regeneration [96]. Similar to ATF3, c-Myc 
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had a hypomethylated promoter, and hypermethylated enhancer regions that were 
demethylated following injury (Figure 3.21). We confirmed the MSRE results with 
bisulfite sequencing [97]. First, we used FACS (fluorescence-activated cell sorting) 
to sort neuronal nuclei using fluorescence-conjugated NeuN. Distal enhancers of 
ATF3 exhibited demthylation following injury, while GAP43 remained methylated 
(Figure 3.22, 3.23). Therefore, demethylation is a tightly regulated, region specific 
process.  
 
Although the data above make it clear that Tet3 is important for the upregulation 
of RAGs, which occurs concomitant with demethylation, further testing was 
necessary to directly connect Tet3 regulation with the demethylation event. 
Therefore, we performed bisulfite sequencing on Tet3 KD samples. We altered our 
Tet3 AAV to express a variant GFP, H2B-GFP, which is detectable while sorting 
nuclei with FACS. We FACS-purified eight groups of NeuN+ nuclei: GFP- 
uninfected neurons or GFP+ neurons expressing either ctrl-shRNA or Tet3-shRNA, 
under either the naive condition or at SNL D1 (Figure 3.24, 3.25). GFP- cells act 
as a natural internal control. In the distal enhancer 1 (DE1) region, a demethylation 
event occurred at SNL D1 in ctrl-shRNA condition, whether GFP+ or GFP-, as well 
as in the Tet3 uninfected GFP- condition. However, Tet3-shRNA GFP+ neurons are 
not demethylated following injury (Figure 3.24, 3.25). Thus, Tet3 is essential for 




3.9 Tet3 recruitment 
ChIP-qPCR (chromatin immunoprecipitation-qPCR) using an antibody against 
Tet3 [98] reveals that there is increased Tet3 binding to the ATF3 DE1 locus, a 
region which exhibited a significant demethylation event, but not to GAP43 loci, 
which remained methylated after injury (Figure 3.26). This indicates that PNS injury 
recruits Tet3 to certain methylated regions of RAGs, leading to the demethylation 
and subsequent upregulation of those RAGs.  
 
3.10 Axon regeneration  
Our data suggest a model wherein Tet3 is recruited via retrograde signaling to 
hypermethylated regions of RAGs. This Tet3 recruitment allows for the 
demethylation and, therefore, upregulation of those RAGs. Given the essential role 
of RAG expression in regeneration, we hypothesized that Tet3 KD was likely to 
have profound consequences for functional regeneration. To test this, we 
competed a functional assessment of the effects of the Tet-shRNA. 
 
First, we used an in vitro neurite outgrowth assay to measure changes in neuron 
growth following Tet3 KD. Purified, primary neurons from adult mouse DRGs were 
disassociated and plated. These cultures were infected with AAV2/9 which co-
expresses GFP and an shRNA against Tet1, Tet2, or Tet3, followed by re-plating, 
which mimics axotomy (Figure 3.27). We found that Tet3 KD reduced both the 
number and the total neurite length of neurite-bearing neurons, while Tet 1 and Tet 
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2 KD were indistinguishable from the control (Figure 3.28, 3.29). In vitro, Tet3 
prevents extension of DRG neuron axons.  
 
Next, we used the AAV Tet3 KD in vivo. We delivered the virus via intrathecal 
injection, as described above. SNL surgery was performed, and whole sciatic 
nerves were removed at SNL D3 and SNL D7. We assessed the extent of 
regeneration using SCG10, which stains regenerating axons [99]. We quantified 
axons in two ways. First, we took longitudinal sections and assessed regeneration 
by fluorescent intensity (Figure 3.30). At SNL D3, sciatic nerves from ctrl-shRNA 
treated animals had extended significantly further than those from Tet3-shRNA 
treated animals (Figure 3.30, 3.31). Because degeneration is still occurring at SNL 
D3, we also removed sciatic nerves at SNL D7, when degeneration is complete 
and all debris has been removed [100]. We cross-sectioned the sciatic nerves at 
1mm intervals (1mm-6mm) along the sciatic nerve, using -1mm to normalize, and 
quantified the number of regenerating GFP+ axons in the coronal sections (Figure 
3.32, 3.33). Tet3-shRNA treated animals exhibited a significant regeneration deficit 
as compared to ctrl-shRNA treated animals (Figure 3.33, 3.34, 3.35). Almost half 
(43%) of Tet3 KD neurons were unable to extend their axons past 1mm, while only 
17% of ctrl-shRNA neurons did not extend past 1mm. Conversely, over 62% of ctrl 
neurons extended axons over 6 mm from the lesion site but only 33% of Tet3 KD 
neurons were able to reach this distance (Figure 3.34, 3.35). We observed no other 
phenotypic differences between the Tet3 and ctrl-shRNA samples, including both 
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morphology and neuronal death rate, ruling out the possibility that regeneration 
differences were due to cellular instability or loss (Figure 3.36, 3.37). 
 
3.11 Sensory recovery 
The fundamental measure of regeneration in the DRG is recovery of sensory input 
and processing. In mice, sensory recovery occurs at 2-3 weeks post-SNL, as the 
sensory neurons begin to re-innervate the skin [101]. To measure the extent of re-
innervation, we took skin biopsies from the mouse hindpaw following SNL, and 
stained for axons using PGP9.5 (Figure 3.38, 3.39). Under naive condition, axons 
of both the Tet3 and ctrl-shRNA neurons fully extend into the epidermis (Figure 
3.40). At SNL D7, all mature, preexisting axons from both the Tet3 and the ctrl-
shRNA neurons had degenerated (Figure 3.39). By SNL D21, the ctrl-shRNA 
neurons had begun re-innervating the epidermis, while Tet3-shRNA neurons were 
mostly non-existent in the skin samples and unable to pass into the dermis (Figure 
3.40, 3.42). We assessed the extent of re-innervation by dividing the dermis and 
epidermis into three layers and quantifying the number of nerve fibers in each layer 
(Figure 3.41). In both the ctrl and Tet3-shRNA groups, naive axons were 
morphologically similar (Figure 3.40). We did not detect a difference in the 
innervation of preexisting axons in the naive samples (Figure 3.42). However, in 
every zone, the Tet3-shRNA SNL group had significantly fewer axons (Figure 
3.42). Thus, Tet3 is required for both regeneration as well as re-innervation into 
the distal target areas.  
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Given that Tet3-shRNA is required for re-innervation of the epidermis, we expected 
that Tet3-shRNA mice would exhibit drastic deficits in sensory recovery. To 
evaluate this, we employed a behavioral test which quantifies the latency of 
hindpaw withdrawal [102]. At intervals between SNL D7 and SNL D21, we 
measured the time for hindpaw withdrawal from exposure to a radiant heat source. 
We first tested the mice before injury to get a baseline reading for the naive 
withdrawal time, and normalized each mouse to their own baseline time. Naive 
mice from both treatment conditions responded similarly, removing the paw quickly 
(Figure 3.43). At SNL D7, latency times were also equivalent. Both groups took 
considerably longer to respond to the stimulus than prior to injury (Figure 3.43). By 
SNL D21, the ctrl-shRNA group had begun to recover, but the latency deficit of the 
Tet-shRNA treatment mice persisted throughout the time course (Figure 3.43). 
Together, these data reveal that Tet3 is an essential component of functional 
recovery in the PNS exhibits.  
 
3.12 TDG  
Although demethylation is one of the Tet proteins’ major roles, it also has many 
noncanonical activities  [103-105]. In addition, 5hmC can independently be used 
as a signaling molecule independently [49, 106, 107]. However, our data suggest 
that the primary role of Tet3 in regeneration is that of demethylation, with 5hmC as 
an intermediate of the active demethylation process (Figure 3.4). In order to clarify 
this role, we also examined the influence of thymine DNA glycosylase (TDG) in 
regeneration. TDG functions together with the base excision repair machinery to 
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restore the oxidative products of demethylation, 5caC (5-carboxylcytosine) and 
5fC (5-formylcytosine), to unmodified cytosine [62, 108].  
 
We hypothesized that, while Tet3 KD led to a decrease in 5hmC, TDG would lead 
to an increase in 5hmC, as the cell is unable to fully demethylate oxidative 
intermediates (Figure 3.4). We engineered a TDG KD AAV, with the same 
backbone and GFP expression of the Tet3 KD virus and delivered it via intrathecal 
injection for in vivo analyses (Figure 3.12). Consistent with previous data, TDG KD 
increased the level of 5hmC in the DRG (Figure 3.44, 3.45) [62, 109]. Similar to 
the Tet3 KD, TDG KD attenuated expression of ATF3, both at D1 and D7 post SNL 
(Figure 3.46, 3.47). ATF3 still retained some expression in the DRG following TDG 
KD, in contrast to the fully-attenuated levels of ATF3 in the Tet3 KD (Figure 3.47). 
This is likely because 5caC and 5fC do not block transcription as 5mC and 5hmC 
do, but rather slow and reduce transcription [110]. qPCR analysis revealed that the 
effect of TDG KD on RAG expression is analogous to that of Tet3. Just as in the 
Tet3 KD animals, SNL-induced transcription is blocked for many RAGs following 
TDG KD, but the expression of some, such as GAP43, do not appear to be under 
the control of the demethylation pathway (Figure 3.48). TDG KD also blocks sciatic 
nerve regeneration, as assessed by coronal sectioning of the sciatic nerve (Figure 
3.32, 3.49, 3.50). We verified this result using TDGf/f KO mice (Figure 3.51, 3.52).  
These data corroborate the model, in which demethylation is the primary role of 
Tet3-mediated RAG expression.  
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3.13 Application to the CNS 
The PNS is an ideal system to identify regeneration factors. As such, we were 
interested in the role of DNA demethylation in the CNS. To investigate this, we 
used a recent model which increased CNS regeneration, PTEN KO, to observe 
the effect of Tet KD [111]. We used the same Tet1, Tet2, and Tet3 shRNAs as 
above, but modified them to target retinal ganglion cells. Tet3 is the only DNA 
demethylase expressed in the PNS, but Tet expression is tissue and context 
dependent (Figure 3.5). Tet1-shRNA treatment reduced the regeneration gain of 
PTEN KO mice (Figure 3.53, 3.54). This indicates that Tet1 is essential to the CNS 
regeneration program induced by PTEN KO. Further, only Tet1 mitigated 
regeneration in the CNS, this suggests that specific expression of the correct set 
of genes will be essential to reprogramming CNS neurons for regeneration.  
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FIGURE 3.1: DRG schematic: Schematic drawing of the DRG structure which lies 
just outside of the spinal cord but is protected by the vertebrae. Each vertebra 
protects its corresponding DRG. Sensory neuron cell bodies are housed in the 
DRG, while motor neuron cell bodies are housed within the spinal cord.   
FIGURE 3.2: SNL schematic: The L4/L5 DRG, together with the motor neurons 
make up the sciatic nerve. SNL surgery is delivered at mid-thigh level.
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FIGURE 3.3. qPCR of epigenetic regulators in DRG: Analysis of expression of 
some known RAGs. The mRNA expression was assessed by qPCR at SNL D1 
and compared to the naive group. Values represent mean ± SEM (n = 3 for each 
group; ***p < 0.001; *p < 0.05; n.s. p > 0.1; two-way ANOVA).   
FIGURE 3.4. Methylation pathway: A schematic diagram illustrating known 
molecular mediators of active DNA demethylation.
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FIGURE 3.5. TET in situ: In situ hybridization of Tet1, Tet2 and Tet3 in näve and 
SNL D1 DRGs and in the adult mouse hippocampus (as a positive control). Scale 
bars: 50 μm. 
FIGURE 3.6. qPCR time course of TET3 expression: Time course of Tet3 
induction in after SNL in DRGs by qPCR analysis. Values represent mean ± SEM 
(n = 3 for each group; *p < 0.05; two-way ANOVA).
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FIGURE 3.7. TET3 in situ, GFP IHC: Sample confocal images of Tet3 in situ, GFP 
immunostaining, and DAPI of L4 DRGs in adult Pirt-GCaMP3 neuronal reporter 
mice under naive conditions and at SNL D1. Scale bar, 20 mm. 
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FIGURE 3.8. TET western blot: Sample western blot image of Tet3 expression 
levels in DRGs under the naive condition and at SNL D1.  
FIGURE 3.9: Pharmacological study of retrograde signaling: Signaling 
mechanism underlying injury-induced Tet3 induction. Adult DRGs were removed 
from the animals and treated with different pharmacological agents, BAPTA-AM 
(50 M), KN92 or KN93 (10 M) for 1 hr, followed by analysis of Tet3 expression 




FIGURE 3.10. 5hmC IHC: Sample confocal image of immunostaining for GFP, 
5hmC, glutamine synthetase (GS), a marker for glia, and DAPI in DRGs of adult 
Pirt-GCaMP3 neuronal reporter mice under naive conditions and at SNL D1. Scale 
bar, 50 mm.
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FIGURE 3.11. qPCR time course of 5hmC induction Quantification of 5hmC 
levels at different time points after SNL. The signal intensity in NeuN+ neuronal 
nuclei of naive L4 DRGs was set as 1.0 and 100–180 neuronal nuclei from each 
condition in three independent experiments were quantified. Values represent 
mean ± SEM (n = 3 for each group; ***p < 0.001; two-way ANOVA).  
FIGURE 3.12. Intrathecal injection schematic A schematic diagram illustrating 
intrathecal injection of AAV to infect L4/5DRG neurons in adult mice in vivo. 
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FIGURE 3.13. AAV efficacy: Sample images of GFP-labeled neurons in DRGs 
at three weeks after AAV2/9 injection which expresses GFP together with either 
control shRNA or Tet3 shRNA. Scale bar: 50 m.  
FIGURE 3.14. 5hmC IHC in Tet3 and ctrl-shRNA: Sample images of 
immunohistochemical analysis of 5hmC levels in Ctrl and Tet3 KD DRG neurons 
under naive conditions and at SNL D1. Shown are sample images (scale bar, 20 
mm) 
 31 
FIGURE 3.15. 5hmC IHC in Tet3 and ctrl-shRNA quantification: quantification. 
Values represent mean ± SEM (n = 3 for each group; ***p < 0.001; two-way 
ANOVA). 
FIGURE 3.16. Dot blot of global 5hmC levels: Dot blot analysis of 5hmC levels 
in DRGs at SNL D1. Neuronal nuclei were enriched from naive and SNL injured 
DRGs via sucrose cushion followed by genomic DNA extraction. 100 ng DNA was 
spotted onto nitrocellulose membrane and 5hmC levels were detected with anti-
5hmC antibody. Shown are sample images and quantification of the signal density. 
Values represent mean + SEM (n = 3; *P < 0.05; two-way ANOVA). 
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FIGURE 3.17. qPCR of RAG expression in Tet3 and ctrl-shRNA: Analysis of 
expression of some known RAGs. The mRNA expression was assessed by 
qPCR at SNL D1 and compared to the Ctrl naive group. Values represent mean 
± SEM (n = 3 for each group; ***p < 0.001; *p < 0.05; n.s. p > 0.1; two-way 
ANOVA).  
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FIGURE 3.18. Tet3 IHC at SNL D1 and D7: Assessment of ATF3 induction in Tet3 
KD DRGs at SNL D1 and D7. Shown are sample images of immunostaining for 
GFP, ATF3, and Glutamine Synthetase (G.S.). in Pirt-GCAMP3 neuronal reporter 
mice and for ATF3 and GFP in normal mice 
FIGURE 3.19. p-c-jun IHC at SNL D1 in WT, Tet3 and ctrl-shRNA: Sample 
images of immunostaining of phospho-c-Jun (p-cjun), GFP, Glutamine Synthetase 
(G.S.) in Pirt-GCaMP3 neuronal reporter mice, and GFP and p-jun in AAV-Ctrl and 
Tet3 shRNA treated DRGs
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FIGURE 3.20. DNA methylation of ATF3: DNA methylation analysis of the ATF3 
genomic loci. Shown in the top panel is a schematic diagram illustrating the 
genomic region of ATF3 gene subjected to analysis. Shown in the middle panel is 
ChIP-seq data on three histone marks from ENCODE to identify genomic features 
of different genomic regions (DE: distal enhancer; PE: proximal enhancer; 4141: 
4141 bp prior to ORF; GB: gene body; ENCODE-LICR-Histone Track, UCSC 
Genome Informatics). Shown in the bottom panel is a summary of DNA 
methylation levels at specific regions. Nuclei harvested from naive or SNL D1 
DRGs were subjected to a sucrose cushion to partially enrich neuronal nuclei. 
Genomic DNA was then digested with either methylation-sensitive (HpaII) or 
insensitive enzymes (MspI). Primers spanning specific CCGG sites were used to 
amplify several putative regulatory regions of ATF3. Values represent mean ± SEM 




FIGURE 3.21. DNA methylation of c-Myc: DNA methylation analysis of the c-
Myc genomic loci, similar to Figure 3.20. Values represent mean ± SEM (n = 3; **P 
< 0.01; two-way ANOVA). 
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FIGURE 3.22. Bisulfite sequencing of ATF3: Bisulfite sequencing analysis of 
ATF3 loci in naive DRG neurons and at SNL D1. NeuN+ neuronal nuclei from L4 
and L5 DRGs were purified by FACS. Each row represents one sequence read 
and each column represents an individual CpG site within the analyzed region. 
Dots represent methylated or unmethylated CpG sites. Numbers indicate the mean 
frequency of methylation at all CpG sites examined (*P < 0.05; Fisher’s exact test).  
FIGURE 3.23. Bisulfite sequencing of GAP43: C-myc methylation, similar to 
Figure 3.22 
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FIGURE 3.24. Bisulfite sequencing of ATF3 in Tet3 and Ctrl-shRNA: Sample 
reads of individual alleles. Open circles indicate unmethylated cytosines and 
closed circles indicate methylated cytosines.
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FIGURE 3.25. ATF3 bisulfite sequencing quantification: Summary from three 
independent biological replicates with at least 20 alleles each. Values represent 
mean ± SEM (n = 3 for each group; *p < 0.05; two-way ANOVA). 
FIGURE 3.26. ChIP of Tet3 binding: ChIP-qPCR analysis of Tet3 binding to 
different genomic regions that were also examined for DNA methylation levels.. 
Values represent mean ± SEM (n = 3 for each group; *p < 0.05; two-way ANOVA). 
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FIGURE 3.27. in vitro culture schematic: Schematic diagram illustrating the 
DRG neuron replating assay for neurite outgrowth. 
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FIGURE 3.28. in vitro culture of DRG neurons: Sample image of neurite 
outgrowth assay (scale bar: 100 μm). 
FIGURE 3.29. Quantification of in vitro culture of DRG neurons: Quantification 
of percentages of neurite bearing neurons and total neurite length. Values 
represent mean ± SEM (n = 3 independent experiments; ***P < 0.001; two-way 
ANOVA).
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FIGURE 3.30. Tet3 KD IHC sciatic nerve regeneration, longitudinal: Analysis 
of regeneration of sensory axons by SCG10 immunostaining at SNL D3. Shown 
are sample images of regenerating sensory axons identified by SCG10 (scale bar, 
500 mm) and quantification 
FIGURE 3.31. Tet3 KD longitudinal sciatic nerve quantification: SCG10 
immunofluorescence intensity was measured at different distal distances and 
normalized to that at the lesion site as the regenerative index. Values represent 
mean ± SEM (n = 5 for each group; *p < 0.05; two-way ANOVA).
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FIGURE 3.32. Sciatic nerve coronal sectioning schematic: A schematic 
diagram of quantification of regenerating axons in the sciatic nerve at distal 
distances from the injury site (set as 0 mm). 
FIGURE 3.33. Tet3 KD IHC sciatic nerve regeneration, coronal: Analysis of 
regenerating axons visualized by GFP labeling at SNL D7. Cross-sections of 
sciatic nerves at 1 to 6 mm distal to the lesion site from AAV-Ctrl and AAV-Tet3 
KD treated animals were analyzed. Shown are sample images of GFP and Tuj1 
(scale bar, 300 mm).
43  
FIGURE 3.34 & FIGURE 3.35. Tet3 KD coronal sciatic nerve quantification: 
Quantification of coronal sections. Values represent mean ± SEM (n = 3–4 for each 
group; *p < 0.05; two-way ANOVA). 
.
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FIGURE 3.36. AAV efficacy: Shown are sample images of cross sections of 
sciatic nerve at three weeks after AAV2/9 injection which expresses GFP together 
with either control shRNA or Tet3 shRNA in the absence of SNL (Scale bars: 50 
m).  
FIGURE 3.37. Caspase-3 IHC: Immunostaining of cleaved caspase 3 (CAS) 
showed little death of DRG neurons under different conditions (scale bar: 50 m).
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FIGURE 3.38. Skin biopsy schematic: Schematic diagrams of skin re-innervation 
assay. Shown is a schematic illustration is a diagram of foot innervation illustrating 
the major innervation of mouse hind paw by both sciatic and saphenous nerves 
and the glabrous footpad regions for skin biopsy. 
FIGURE 3.39. Nerve fiber IHC, naive and D7: Sample images of skin nerve fibers 
from naive and Tet3 and ctrl-shRNA animals at D7 after SNL and saphenous nerve 
ligation. Note that there is complete denervation of GFP+ axons in the footpad skin 
at D7 after injury for both control and Tet3 KD animals. Scale bar: 20 m.
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FIGURE 3.40. Nerve fiber IHC, D21: Assay of re-innervation of epidermal area of 
the hindpaw by regenerating sensory axons. Shown are sample images of cross 
sections of hindpaw glabrous skin of Ctrl and Tet3 KD mice immunostained with 
the pan neuronal marker PGP9.5. The dotted line indicates the border between 
dermis and epidermis (Scale bar, 20 mm). 
FIGURE 3.41. Skin biopsy quantification schematic: Shown is a schematic 
diagram zones we designated for quantification.
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FIGURE 3.42 Skin biopsy quantification: Quantifications of the number of 
intraepidermal nerve fibers in a 1 mm segment of different epidermal areas. Values 
represent mean ± SEM (n = 4 for each group; **p < 0.01; *p < 0.05; n.s. p > 0.1; 
two-way ANOVA). 
FIGURE 3.43. Thermal hindpaw withdrawal assay: Assessment of thermal 
sensory recovery after SNL in AAV-Ctrl and AAV-Tet3 KD treated animals. Values 
represent mean ± SEM (n = 9–12 animals per group; **p < 0.01; ***p < 0.001; two- 
way ANOVA).
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FIGURE 3.44. 5hmC IHC in TDG KD: Immunohistochemical analysis of 5hmC 
levels in Ctrl and TDG KO DRG neurons of näve and SNL D7 animals. Same as 
in Figure 3.14 (scale bar, 20 mm). 
FIGURE 3.45. Quantification of 5hmC IHC in TDG KD: Quantification of TDG-
shRNA 5hmC levels. Values represent mean ± SEM (n = 3; **P < 0.01; two-way 
ANOVA).
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FIGURE 3.46. ATF3 IHC in TDG KD: Assessment of ATF3 induction in TDG KO 
DRGs. Similar to Figure 3.18, shown are sample images (scale bar, 20 mm). 
FIGURE 3.47. Quantification of ATF3 IHC in TDG KD: Quantification of ATF3 
time course in TDG and ctrl-shRNA. Values represent mean ± SEM (n = 4 for each 
group; **p < 0.01; two-way ANOVA).
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FIGURE 3.48. qPCR of RAG expression in TDG and ctrl-shRNA: TDG-
dependent expression of multiple SNL- induced RAGs. The mRNA expression was 
assessed by qPCR at SNL D1 and compared to the Ctrl naive group. Values 
represent mean ± SEM (n = 3 for each group; ***p < 0.001; **p < 0.01; *p < 0.05; 
n.s. p > 0.1; two-way ANOVA).
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FIGURE 3.49. TDG KD IHC sciatic nerve regeneration, coronal: In vivo axon 
regeneration assay. Similar to Figures 3.33. Shown are sample images (scale bar, 
300 mm) at SNL D7 with expression of control-shRNA or TDG-shRNA.  
FIGURE 3.50. TDG KD coronal sciatic nerve quantification: Quantification of 
coronal sections. The same data from Ctrl-shRNA in Figure 3.34 is replotted for 




FIGURE 3.51. TDG KO IHC sciatic nerve regeneration, longitudinal: Similar to 
Figures 3.30 and Figure 3.31. Shown are sample images of regenerating sensory 
axons identified by SCG10 (scale bar, 500 mm) in TDGf/f mice expressing GFP 
(Ctrl), or GFP and Cre (TDG-KO) and quantifications 
FIGURE 3.52. TDG KO longitudinal sciatic nerve quantification: Quantification 
of regeneration in TDG KO. Values represent mean ± SEM (n = 4 for each group; 
*p < 0.05; two-way ANOVA).
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FIGURE 3.53. PTEN/Tet KD IHC: Adult Ptenf/f mice were injected with AAVs to 
co-express GFP, Cre, and control shRNA, or shRNA against Tet1, Tet2, or Tet3, 
followed by optic nerve crush 2 weeks later. RGC axons were anterogradely 
labeled by cholera toxin b subunit 12 days after injury. Shown are sample images 
of labeled axons (scale bar, 20 mm). 
FIGURE 3.54. PTEN/Tet KD quantification: Quantification of PTEN KO optic 
nerve regeneration. Values represent mean ± SEM (n = 3 for each group; *p < 
0.05; two-way ANOVA). 
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CHAPTER 4 - DISCUSSION 
In the PNS, mature, post-mitotic neurons are able to activate a pro-regenerative 
program that not only produces axon regrowth and proper axon targeting, but can 
fully restore the functionality of injured neurons [1, 112]. Together with extrinsic 
factors, the intrinsic system is an important component of regeneration [3, 113]. In 
this study, we have identified a critical component of the intrinsic pro-regenerative 
program that is essential for PNS regeneration, DNA demethylation. Together with 
histone modifications, DNA methylation regulates intrinsic regeneration capacity 
[78]. In addition to offering insight into the basic biology of regeneration, this new 
data suggests novel therapeutic targets for both PNS and CNS regeneration.  
 
4.1 Current models of CNS regeneration 
The existing methods to increase regeneration in the CNS show surprising 
potential. For example, the PTEN KO described above has been further improved 
and refined by synergistically combining other regulatory elements, such as the 
PTEN/SOCS3 double KO [111, 114, 115]. However, PTEN is an oncogene, and 
therefore, not ideally suited to be a therapeutic target [116, 117]. Our work with 
PTEN suggests that there is an epigenetic component to the observed 
regeneration phenotype (Figure 3.53, 3.54). With further development, one 
potential application is the upregulation of pro-regenerative regulatory elements 
such as Tets or HATs (Figure 3.53) [78]. Still, much further research is necessary 




4.2 Tet1 Overexpression 
Our data suggest that Tet1 is essential for PTEN-related regeneration gains in the 
CNS (Figure 3.53). However, additional experiments in our lab using the 
overexpression of Tet1 were unsuccessful in increasing CNS regeneration. 
Although PTEN KO-associated regeneration requires Tet1, Tet1 overexpression 
alone is not sufficient to cause an increase in regeneration. There are likely many 
reasons for this. First, when the peripheral nervous system upregulates Tet3, it 
also targets it to the correct methylated loci. Our data show that Tet3 does not bind 
every methylated enhancer, even those within essential RAGs, such as Gap43 
(Figure 2.17, 2.26). Thus, the simple upregulation of single regulatory factors is 
unlikely to be successful. One future direction of this work, as well as the wider 
epigenetic field, is to better understand how epigenetic regulators find their correct 
targets. A second possible reason Tet1 upregulation is unsuccessful as an 
independent therapeutic target is the role of translation. Although this work has 
focused on the role of transcription in regeneration, translation is also an essential 
component of the wider intrinsic regenerative program. Large amounts of newly-
synthesized protein are required to successfully repair and extend injured axons 
[118].  
 
4.3 m6A and regeneration 
One way that the PTEN KO model successfully induces regeneration is by 
activating the mTOR pathway [111]. In the PNS, the mTOR pathway is active both 
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under basal conditions and after injury [96, 119].  However, in the CNS, mTOR 
signaling declines as the neuron matures, and is completely blocked upon CNS 
injury [96]. 
 
mTOR is a regulator of cap-dependent translation [120]. Based on the connection 
between PTEN and cap-dependent translation, a new direction in our lab has 
focused on the role of the epitranscriptome in the regulation of translation efficiency 
after SNL. The epitranscriptome is comprised of a diverse group of chemical 
modifications on RNA, and associated RNA binding proteins, which dynamically 
regulates the fate of RNA. To date, many modifications have been discovered, 
including N6-methyladenosine (m6A), N1-methyladenosine (m1A), and 5-
methylcytosine (m5C) [121-124]. Of these modifications, m6A is the most 
abundant, and, together with its binding partners, has been show to increase 
translation [125, 126]. An ongoing project in our lab focuses on the role of m6A in 
PNS regeneration. Our data suggests that m6A is a regulator of protein translation 
following SNL. Therefore, m6A opens a new avenue in regeneration, protein 
translation regulation and the epigenome.  
 
Like Tet1 OE, modulation of m6A is also unlikely to independently promote proper 
regeneration in the PNS. It has been suggested that mTOR is dispensable for 
axonal regeneration in the PNS because rapamycin, a specific mTOR inhibitor, 
does not suppress the axon growth in the DRG [38, 127]. Indeed, even with an 
increase in translation, the PNS still requires proper de novo transcription of 
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epigenetically silenced RAGs. Therefore, true gains in therapeutic CNS 
regeneration are likely to involve a regulated system of transcription and 
translation. Further, any model must work within the context of the individual cell 
targeted.  
 
4.4 Other methods of CNS regeneration 
Although great gains have been made by applying PNS regeneration factors to the 
CNS, the CNS itself has also yielded important data. For example, a small injury 
in the CNS which occurs before a large injury preconditions the CNS to respond 
more favorably. This preconditioning not only prevents neurons from undergoing 
apoptosis, but can lead to gains in regeneration [128, 129]. As the conditioning 
lesion must be delivered before the injury, the method is of little therapeutic 
consequence. However, understanding what factors are upregulated in the CNS 
as a result of the conditioning lesion has provided valuable insight into CNS 
regeneration. For example, cAMP injection appears to approximate the 
regenerative program of the preconditioned CNS [130-133]. Combing the insights 
learned from the PNS with the preconditioning CNS model might be a good way 
to better understand the intricacies of CNS regeneration. As an illustration, we 
discovered the role of Tet3 in regeneration using the PNS as a model system. In 
the PTEN KO model, Tet1 was implicated, but the use of Tet1 overexpression 
alone was insufficient to cause CNS regeneration. Now that the role of DNA 
demethylation in PNS regeneration has been illuminated, the role of Tet can be 




4.5 CNS development and regeneration  
The fetal CNS offers another model for CNS regeneration. During development of 
the nervous system, regeneration is robust and precise after injury [70]. As 
discussed above, neurons proceed down a developmental path that silences fetal 
gene expression and activates those genes essential for the mature neuron [59]. 
In the CNS, neurons are competent to regenerate until just after birth in mice [70]. 
This signaled loss of regenerative capacity is mediated by cellular transduction 
[70]. Neurons that do not receive the signal to turn off axon growth persist in their 
regenerative ability. Further, neurons that receive the signal and switch to dendritic 
growth, retain this state even if the signal is removed [70]. Therefore, it is probable 
that epigenetic factors program the neuron’s switch from an axon growth state to 
an adult, non-regenerative state. Preliminary data in our lab suggests that several 
epigenetic modifiers are upregulated at the time of the transition from axonal to 
dendritic growth. Once mature CNS neurons have reached their target, they are 
unable to reform a growth cone or synthesize the cytoskeletal elements necessary 
for axon elongation [134]. Therefore, if the CNS neuron could be returned to its 
embryonic growth state, for instance through modulation of epigenetic factors, the 
cell could be induced to regenerate as it does before reaching maturity. This, 
however, comes with two major caveats. First, there is no guarantee that the 
regenerative program matches embryonic development. Indeed, the PNS clearly 
has a special program for regeneration. Second, there are many signals, from 
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many different cells, that give guidance and growth cues to the developing neuron. 
Clearly, regeneration will require proper orchestration of a large variety of cells.  
 
4.6 Preconditioning and adult neurogenesis 
There are also two innate ways that adult CNS neurons can produce new growth. 
First, specific centers of the brain can produce fully functional new neurons from 
existing adult precursors in a process known as adult neurogenesis [135, 136]. 
Because these cells develop in the brain without manipulation, they integrate into 
the existing neural network seamlessly. Therefore, these newborn neurons could 
be useful as a system-wide approach to understanding how regenerative CNS 
growth could be acclimatized. The two major regions of neurogenesis in mammals 
are the olfactory bulb and the dentate gyrus of the hippocampus [137, 138]. 
Second, it has been suggested that there are other, non-neurogenic zones in 
which reactive astrocytes, a major hallmark of CNS injury, might be reprogrammed 
to form new neural progenitor cells [139-141]. This suggests that, despite the 
extrinsic limitations of the CNS, intrinsic programs can allow for axon extension.  
 
Together, the data on CNS growth, axon extension, and regeneration reveals a 
dynamic, tightly regulated system. Although CNS neurons are mature and post-
mitotic, it is possible that functional connections can be made after injury. However, 
the CNS, like the PNS, is a heterogeneous system. Therefore, therapeutic 
approaches will likely need to be discrete and specific. It is possible that each 
individual cell of the nervous system will require its own pro-regenerative system.  
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4.7 Applications to the PNS 
Due to of the huge burden of morbidity and mortality in CNS disease, it is 
necessarily a major focus of regenerative research [2]. However, the PNS also 
presents regeneration hurdles. As an organism ages, the PNS gradually loses its 
ability to regenerate [142-144]. In rodents, the number and speed of regenerating 
axons is greatly reduced with age [143, 145]. In addition, neurodegeneration is a 
critical problem amongst many common diseases, including Parkinson’s and 
diabetes [146]. Gains in PNS regeneration will also be of great benefit to PNS 
disease.   
 
4.8 Other epigenetic factors 
This work, together with previous studies, has identified the role of epigenetic 
modifications in PNS regeneration. A current study in the lab is expounding on the 
role of m6A, an RNA modification. However, there are still many more regulatory 
epigenetic elements that have not yet been investigated. For example, m6A is only 
one of a number of RNA modifications that have been shown to effect translation 
and stability of RNA molecules [124]. There are still many other epitranscriptomic 
modifications that have not yet been investigated. Further, the organization of 
genome under PNS injury is still unexplored. Methods such as ATAC-seq have 
shown large genomic changes with neuronal activity in the CNS [76, 147]. 
Alteration of the chromatin landscape changes accessibility of the DNA to a wide 
variety of proteins, such as transcription factors and the transcription machinery, 
thereby altering genomic expression. In addition, recent mapping of the 3D 
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structure of the genome has yielded insight into genomic neighborhoods that 
function together, insulated from nearby neighborhoods [148, 149]. Although the 
upregulation of many RAGs was explained by Tet3, some, such as GAP43, were 
not demethylated, and are, therefore, regulated by a different method, possibly 
through chromatin architecture (Figure 3.22, 3.23). 
 
4.9 Soma and axon growth 
The molecular data in this work was collected exclusively in the soma. As the 
center of transcription, the soma provides the essential blueprint for regeneration. 
However, the ends of the regenerating axons are also extremely active. These 
distal regions must coordinate the work of rebuilding an axon. For example, 
because of the extensive distance between the soma and growth cone, many 
mRNAs are transported from the soma, and protein synthesis occurs on site [150-
152]. Although technical limitations make studying RNA molecules in the axons 
difficult, recent advancements are allowing interrogation of this system [153]. A 
better understanding of which mRNAs are transported to the axons ends and how 
this regulatory system functions will add greatly to the knowledge of how PNS 
regeneration occurs. Future work in this area should address the role of RNA 
modifications, m6A and others, in the packaging and transport of mRNAs, as well 






This work has focused on a small but essential component of regeneration: 
regulation of intrinsic RAG expression. We found that Tet3 is upregulated through 
retrograde signaling, in turn demethylating and upregulating RAGs. Adult neurons 
regulate the expression of these genes though the combined activity of epigenetic 
factors. In the PNS, these regulatory elements can be reprogramed within the adult 
cell to allow for functional regeneration. Although there is still much to be explored, 




FIGURE 4.1. Graphical abstract of thesis: SNL upregulates Tet3 in the dorsal 
root ganglion. Tet3 is recruited to and demethylates regions of specific, key RAGs, 
allowing their expression. The upregulation of transcription is a key component of 




CHAPTER 5 - METHODS 
5.1 AAV constructs 
Ctrl shRNA and shRNAs for mouse Tet1, Tet2, and Tet3 were previously 
characterized [88, 154]. Tet3 shRNA efficacy was further validated by qPCR in 
DRG neurons both in vitro and in vivo (Figure 5.1). shRNA for mouse TDG 
contained the following short-hairpin sequence: AAATGTCAGGAAGAGTCTTGG 
and its efficacy was validated by qPCR in the DRG in vivo (Figure 5.2). High titers 
of recombinant AAV2/9 virus transducing shRNA were generated as previously 
described [154, 155]. In addition, the recombinant AAV2/9 vector for Cre was 
purchased from the UPenn Vector Core. 
 
5.2 DRG cultures and neurite outgrowth assay 
For cell culture experiments, lumbar DRGs from adult mice were rapidly dissected 
and digested in a solution of Collagenase II (200 U/mL, Worthington Biochemical 
Corporation, Lakewood, NJ) and Dispase II (2.5 U/mL, Roche Diagnostics) in 
HBSS at 37 C for 30 min. Tissues were then mechanically dissociated into cell 
suspension by gentle trituration with a 1 mL pipette tip. The cell suspension was 
layered on a BSA cushion (10% w/v in F12/MEM) and centrifuged at 600 g for 15 
min to remove myelin and axon debris. Purified neurons were then cultured on 
laminin-coated coverslips in F12/MEM media complemented with 10% FBS and 
penicillin-streptomycin at 37 C. Cultures were infected with AAV co-expressing 
GFP and different shRNAs for 5 days. Cultures were then trypsinized (0.025% 
Trypsin-EDTA) for 5 min at 37 C, gently triturated in fresh medium with 10% FCS, 
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and cultured for additional 16 hr. Cells were fixed with 4% PFA and neurites were 
visualized by immunostaining of -tubulin (Tuj1; Sigma, 1:1000). The percentage 
of neurons bearing neurites was quantified by counting those with neurites longer 
than the diameter of its soma. The length of the longest neurite in each cell was 
measured in neurite-bearing neurons using the NeuronJ software. Approximately 
150 cells were scored per condition and three independent sets of experiments 
were performed.  
 
For the pharmacological experiments, lumbar vertebrae were rapidly dissected 
and treated with BAPTA-AM (50 mM), KN92 or KN93 (10 mM) in DMEM/F12 media 
for 1 hr at 37 C in a humidified atmosphere containing 5% CO2. Total RNA was 
then isolated from the DRG using TRIzol and RNA Clean and Concentrator (Zymo 
Research) for the subsequent qPCR assay. 
 
5.3 Animal surgery 
For intrathecal injection of AAV2/9 virus, adult mice were anesthetized and shaved 
to expose the skin around the lumbar region. A total of 3 mL of viral solution was 
injected to cerebrospinal fluid between vertebrae L5 and L6 using a 30 gauge 
Hamilton syringe. The injection needle was left in place an additional 2 min to allow 
the fluid to diffuse. Mice were left to recover for 3 weeks to ensure substantial viral 
expression prior to behavioral or surgical procedures.  
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For the SNL surgery, mice were anesthetized and a small incision was made on 
the skin at the mid-thigh level. The sciatic nerve was exposed after opening the 
fascial plane between the gluteus superficialis and biceps femoris muscles. The 
nerve was carefully freed from sur- rounding connective tissue and then crushed 
for 15 s at 3 clicks of ultra-fine hemostatic forceps (F.S.T. 13021-12). The crush 
site was labeled by stitching a 10-0 nylon suture through the epineurium. The skin 
was then closed with two suture clips. For the sham (naive) surgery, the sciatic 
nerve of the contralateral side was exposed and mobilized but left uninjured. For 
the thermal withdrawal test and skin biopsy experiments, the saphenous nerve 
was ligated and transected above the knee region after sciatic nerve crush, so that 
the hind paw epidermis can only be innervated by regenerating sciatic nerve 
axons. 
 
5.4 Behavioral analysis 
The thermal withdrawal behavioral test was performed following a previously 
established protocol [102]. Briefly, mice were placed on a glass surface with a 
consistent temperature of 30 C. The plantar surface of hind paw was tested using 
a focused, radiant heat light source (model 33 Analgesia Meter; IITC/Life Science 
Instruments, Woodland Hills, CA, USA). A timer linked to the light source was used 
to measure the paw-withdrawal latency. Only quick hind paw movements away 
from the stimulus were considered to be a withdrawal response, and seven 
individual measurements were repeated for each paw. 
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5.5 In situ hybridization 
In situ hybridization was performed on PFA-fixed DRG sections (20 mm thickness) 
as described previously [74, 156]. Digoxigenin-labeled antisense riboprobes 
specific for the coding sequences of mouse Tet1 (3353-3860 bp), Tet2 (2808-3366 
bp) and Tet3 (4977-5616 bp) were generated using the DIG RNA labeling kit 
(Roche Applied Science) according to the manufacturer’s instructions. DRG 
sections were hybridized with riboprobes at 60 C overnight, and then washed once 
in 5X SSC and three times in 0.2X SSC for 30 min each at 60 C. DRG sections 
were incubated with alkaline phosphatase-conjugated anti-digoxygenin antibody 
at 4 C overnight and developed in nitroblue tetrazolium (NBT, 35 mg/ml)/5-bromo-
4-chloro-3-indolyl phosphate (BCIP, 18 mg/ml) solution at room temperature to 
visualize hybridized riboprobes. Experiments for different conditions were 
processed in parallel for comparison. For the combined immunocytochemistry and 
fluorescence in situ, the same in situ procedure was followed as above with the 
following exceptions. First, an RNA probe was generated and conjugated to alexa 
fluor 594 (FISH Tag #F32954). Second, in situ hybridization was followed by 
immunostaining for GFP (goat anti-GFP Rockland; 1:500), incubated at 4 C 
overnight and followed by a two-hour room temperature incubation of cy2-
conjugated secondary (Jackson ImmunoResearch; 1:500). 
 
5.6 Western blot analysis 
L4/L5 injured or naive DRGs were rapidly dissected and extracted protein samples 
were run on 4%–16% Mini-PROTEAN TGX Pre- cast Protein Gels (Bio-rad) and 
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transferred to PVDF membrane using the transblot turbo system (Biorad) following 
manufacturer’s instructions. The membrane was blocked overnight in 5% dry milk 
at 4 C with rocking. Anti-Tet3 antibodies (Abiocode; 1:1000) were applied overnight 
at 4 C followed by HRP-conjugated mouse anti-mouse IgG antibody (Santa Cruz; 
1:4000). Protein loading was verified by mouse anti-GAPDH. 
 
5.7 Gene expression and methylation analyses 
For qPCR analysis, L4 and L5 DRGs were rapidly dissected from adult mice and 
homogenized with Trizol (invitrogen) to extract total RNA. Isolated RNA was 
reverse transcribed to cDNA (Invitrogen) and the expression level of target genes 
was measured by qPCR with Fast SYBR Green Master Mix (ABI). Specific primers 
used in this study are listed in Table 1. 
 
A restriction enzyme-based methylation assay was performed to quantify levels of 
DNA methylation at select loci in mouse DRG DNA as previously described [50, 
157]. Briefly, 500 ng of genomic DNA from neuronal nuclei enriched by a sucrose 
cushion method were digested with MspI, HpaII or mock for 8 hr at 37 C. The 
reaction was stopped by treatment of proteinase K for 10 min at 40 C and heat-
inactivation for 5 min at 95 C. DNA samples were then diluted with ddH2O to 150 
mL final volume and were assayed by Q-PCR (Applied Biosystems 7500) using 
Power SYBR Green PCR Master Mix (Applied Biosystems). Primers flanking 
specific HpaII digestion sites (CCGG) are listed in Table 2. 
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5.8 In vivo DRG axon regeneration assay 
Adult mice were anaesthetized and perfused with 4% PFA in PBS. For cross-
section analyses, the sciatic nerve was harvested at 7 days-post crush when 
degeneration of preexisting axons of mature neurons was complete (Di Maio et al., 
2011; Shin et al., 2012). DRGs were dissected and post-fixed in fixative at 4 C for 
5 min. The sciatic nerve was post-fixed overnight, and the cryoprotected in 30% 
sucrose (wt/vol) for 24 hr at 4 C. The nerve was sectioned into 10 mm thickness 
at every 1 mm, from 1 mm proximal to injury site (-1) to 6 mm distal to injury site. 
The sectioned nerves were stained with anti-GFP antibody and the total number 
of axons was quantified at each distance by using ImageJ software. The section (-
1) proximal to injury site served as control and the axon number in other sections 
was normalized to the control for each animal to assess the regeneration rate. 
 
For the longitudinal sections assay, sciatic nerves were dissected at SNL D3 and 
postfixed with 4% PFA. Longitudinal sections were stained with SCG10 (Novus 
Biologicals, NBP1-49461). SCG10 fluorescence intensity was measured by NIH 
ImageJ along the distance as previously described [100, 158]. An SCG10 intensity 
plot was drawn with average intensities calculated from non-overlapping 10 mm 
regions and normalized to that observed at the crush site. 
 
5.9 Immunohistochemistry  
IHC was performed as described previously [159]. The slides were incubated with 
primary antibodies at 4 C overnight. Primary antibodies used in this study include: 
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mouse anti-Tuj1 (Sigma; 1:1000 or BioLegend; 1:2000), mouse anti-phospho-c-
Jun (Cell Signaling; 1:300), rabbit anti-5hmC (Active Motif; 1:5000), rabbit anti-
ATF3 (Santa Cruz; 1:500), rabbit anti-PGP9.5 (AbD Serotec; 1:800), goat anti-GFP 
(Rockland; 1:500), mouse Anti-NeuN (Millipore; 1:500), mouse anti-Glutamine 
Synthetase (Santa Cruz sc-74430; 1:300), rabbit anti-SCG10 (Novus Biologicals, 
NBP1-49461, 1: 2000), and anti-cleaved (active) form of caspase 3 (Invitrogen, 
9H19L2; 1:500). Cy2–, Cy3– or Cy5–conjugated secondary antibodies (Jackson 
ImmunoResearch; 1:500) to appropriate species were incubated at room 
temperature for 2 hr. The images were acquired by confocal microscopy (Zeiss 
710). 
 
Images were analyzed with ImageJ software (National Institutes of Health). 
Quantification of the proportion of ATF3 or p-c-Jun ex- pressing DRG neurons was 
determined by counting the number of immunoreactive (with nuclear signal) and 
non-immunoreactive (without nuclear signal) neurons. The cutoff value for 
determining the threshold of immunoreactivity was based on the negative cells in 
naive samples processed in parallel. All cells with fluorescence signal above 
threshold were considered positive. At least 50 GFP+ DRG neurons per mouse 
were counted on randomly chosen sections from L4 and L5 DRGs. 
 
For skin biopsies, glabrous footpad skin from hind paws was harvested by punch 
biopsy. The biopsy was immersion-fixed in Zamboni’s fixative overnight at 4 C, and 
cryoprotected in 30% sucrose. The specimens were then sectioned at 20 mm, 
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mounted on gelatin coated slides and stained with rabbit anti-PGP9.5 antibody to 
visualize nerve fibers. To quantify regenerative nerve fibers, we defined 3 zones 
based on the structure of skin. Zone 1 is the dermis layer where the subepidermal 
nerve plexus length (SNPL) was determined and divided by the length of 
epidermis. Zone 2 and Zone 3 are defined based on the boundary between stratum 
granulosum (SG) and stratum spinosum (SS) sub-layers in epidermis. The density 
of epidermal nerve fibers was measured by counting numbers of nerve fibers per 
mm of epidermis. Nerve fibers branching within Zone 3 were counted as one, 
whereas nerve fibers branching within Zone 2 were counted separately. 
 
5.10 Neuronal nuclei isolation 
For 5hmC quantification, we enriched DRG neurons with a sucrose cushion 
method [160]. Briefly, frozen DRG tissues were ground into fine powder in a dry 
ice/ethanol cooling bath and homogenized in 3 mL of hypotonic buffer containing 
20 mM Tris-HCl (pH 7.4), 10 mM NaCl, and 3 mM MgCl2. Samples were then 
suspended in nuclei resuspension buffer containing 3 mM MgCl2, 5 mM CaCl2, 10 
mM Tris-HCl (pH7.5), 0.5 mM DTT, 1x proteinase inhibitor (Roche), and 0.32 M 
sucrose. The crude nuclei were layered onto a sucrose cushion buffer containing 
0.5 mM MgCl2, 0.5 mM DTT, 1x proteinase inhibitor, and 0.88 M sucrose, and 
centrifuged at 2800 g for 15 min at 4 C to enrich the neuronal nuclei population. 
The neuronal nuclei were then resuspended in nuclei resuspension buffer for 
cytometry analysis or methylation sensitive qPCR analysis. 
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5.11 5hmC dot blot analysis 
Dot blot analysis of 5hmC was performed as previously described [88, 154]. Briefly, 
genomic DNA samples from different treatment groups were adjusted to a 
concentration of 100 ng/ml, heat-denatured at 95 C for 5 min, and chilled on ice 
for 1 min. Samples were applied to Hybond-N+ membranes (GE Healthcare), and 
then cross-linked by a UV stratalinker 1800 (Stratagene). Membranes were 
blocked by 5% dry milk (wt/vol), and incubated with anti-5hmC antibody (Active 
Motif; 1:5,000) followed by HRP-conjugated donkey anti-rabbit IgG antibody 
(Santa Cruz; 1:1000). Signal was visualized by SuperSignal West Pico 
Chemiluminescent Substrate (Thermoscientific). 
 
5.12 Bisulfite sequencing 
Bisulfite sequencing analysis was performed as previously described [74]. Briefly, 
genomic DNA was bisulfite converted using commercial reagents (Zymo 
Research). The converted DNA was then used as a template for PCR amplification 
of regions of interest with specific primers (listed in Table 3). PCR products were 
gel-purified and cloned into the pCR 2.1 TOPO vector (Invitrogen). Individual 
clones were sequenced and aligned with the reference genomic sequence. 
 
5.13 ChIP analysis 
Freshly dissected DRGs were cut into fine pieces and incubated in 1% 
formaldehyde (Sigma) in Dulbecco’s PBS (DPBS) for 15 min at room temperature 
with continuous rocking. 0.125 M glycine was added to the solution and incubated 
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for 5 min to quench cross-links. After washing twice with ice-cold DPBS, tissue 
pieces were resuspended in cell lysis buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 
and 1% SDS), homogenized using a Dounce homogenizer (Kimble Chase) and 
then incubated on ice for 30 min. The samples were sonicated by a Bioruptor plus 
(Diagenode) for 25 cycles (30 s on, 30 s off) at the high intensity setting. After 
centrifugation, the supernatant was diluted 10 times in IP dilution buffer (0.01% 
SDS, 1.1% Triton X-100, 16.7 mM Tris-HCl pH 8.0, 1.2 mM EDTA, and 167 mM 
NaCl). Anti-Tet3 (Jin et al., 2016) or rabbit IgG (3 mg; Cell Signaling 2729) 
antibodies were added and incubated at 4 C over- night. Protein G Dynabeads 
(Life Technologies) were then added to the samples and incubated at 4 C for 2 hr. 
The beads were washed twice with low-salt wash buffer (0.1% SDS, 0.1% Triton 
X-100, 2 mM EDTA, 20 mM Tris pH 8.0, and 150 mM NaCl), twice with high-salt 
wash buffer (0.1% SDS, 0.1% Triton X-100, 2 mM EDTA, 20 mM Tris pH 8.0, and 
500 mM NaCl), twice with IP wash buffer (1% deoxycholic acid, 1% Igepal, 100 
mM Tris pH 9.0, and 500 mM LiCl) and twice with TE buffer (10 mM Tris-HCl pH8.0 
and 1 mM EDTA). Freshly made elution buffer (1% SDS and 0.1 M NaHCO3, pH 
8.0) was added to the beads, and chromatin was eluted at 65 C in a thermomixer 
for 1 hr. After removing beads, crosslinking was reversed in 0.3 M NaCl solution 
at 65 C overnight. Proteinase K (NEB) was then added to the decrosslinked 
chromatin solution and incubated for an additional 2 hr at 55 C. The eluted DNA 
fragments were extracted using phenol:chloroform:isoamyl alcohol (25:24:1) and 
precipitated by isopropanol and glycogen. Region-specific primers for Q-PCR are 
listed in Table 4. 
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5.14 Optic nerve injury and quantification 
The procedure was performed as previously described [111]. Briefly, Individual 
AAV-shRNA for Ctrl, Tet1, Tet2, and Tet3 was mixed with AAV-Cre and 
intravitreally injected to the left eyes of adult PTENf/f mice. Two weeks after viral 
injection, the left optic nerve was exposed intraorbitally and crushed with jeweler’s 
forceps (Dumont number 5; Roboz) for 5 s, approximately 1 mm behind the optic 
disc. To visualize regenerating axons, RGC axons in the optic nerve were 
anterogradely labeled by 1 ml of cholera toxin b subunit (CTB; 2 mg/ml; Invitrogen) 
12 days after injury. Animals were fixed by 4% PFA 2 days after CTB injection in 
the eye. Quantification of regenerating axons was also performed according to 
previously described methods [111]. Specifically, for each animal the number of 
CTB labeled axons was estimated by counting the number of CTB-labeled fibers 
extending different distances from the end of the crush site in 5 sections (every 4th 
section) per animal. The cross-sectional width of the nerve was measured at the 
point at which the counts were taken and was used to calculate the number of 
axons/mm of nerve width. The number of axons/mm was then averaged over all 
sections. ad, the total number of axons extending distance d in a nerve having a 
radius of r, was estimated by summing over all sections having a thickness t (8 






5.15 Animals  
Four mouse lines were used for this study. C57Bl6/J mice, used as WT in all 
experiments, were purchased from Charles River. A DRG neuron reporter mouse 
line that expresses GCaMP3 from the endogenous Pirt locus was a gift from 
Xinzhong Dong [86]. The TDGf/f mouse line was a gift from Alfonso Bellacosa (A.B., 
unpublished data). The Ptenf/f mouse line was a gift from Zhigang He [111]. Adult 






FIGURE 5.1. Quantification of Tet3 KD efficacy: Quantification of the efficacy of 
Tet3 shRNA in vitro. Values represent mean ± SEM (n = 3; *P < 0.05; two-way 
ANOVA) 
FIGURE 5.2. Quantification of TDG KO efficacy: In vivo knockdown efficacy of 
TDG shRNA. Adult DRGs were infected with AAV-TDG shRNA or ctrl- shRNA via 
intrathecal injection. TDG expression was analyzed 21 days later by qPCR.
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TABLE 1: qPCR primers of epigenetic regulators and RAGs 
GAPDH_F   AAGAAGGTGGTGAAGCAGGCATCT  
GAPDH_R  ACCCTGTTGCTGTAGCCGTATTCA 
 
Tet1_F  GAGCCTGTTCCTCGATGTGG 
Tet1_R   CAAACCCACCTGAGGCTGTT  
 
Tet2_F   TGTTGTTGTCAGGGTGAGAATC  
Tet2_R  TCTTGCTTCTGGCAAACTTACA  
 
Tet3_F   CCGGATTGAGAAGGTCATCTAC  
Tet3_R   AAGATAACAATCACGGCGTTCT  
 
TDG_F   CCATGTAATGGGGAACCTTG  
TDG_R  AAGGGATCTGCTCTGCAAAC  
 
Gadd45a_F   TGAGCTGCTGCTACTGGAGAACGAC  
Gadd45a_R   TCCTTCCATTGTGATGAATGTGGGT  
 
Gadd45b_F   GCCCGAGACCTGCACTGCCT  
Gadd45b_R   CCATTGGTTATTGCCTCTGCTCTCTT  
 
Gadd45g_F   GGAGACCTGCATTGCATCCTCATTT  
Gadd45g_R   ACTCGGGAAGGGTGATGCTGG  
 
Apobec1_F   TCAGGGACCTTATTAGCAGCGG  
Apobec1_R  GCCAATAAGCTTCGTTTGAAGGG  
 
Apobec2_F   GACAATGGTGGCAGGCGATTCA  
Apobec2_R   GCAGAGATGCTTGACTCGTTGG  
 
Apobec3_F   TGCTACTACCACCGCATGAA  
Apobec3_R   CAGCTCCATGGACCGAATCT 
 
AID_F   GCCACCTTCGCAACAAGTCT 
AID_R  CCGGGCACAGTCATAGCAC 
 
DNMT1_F  GAGGCGGAAATCAAAGGAGGA 
DNMT_R  GGGAGTCTCTGGAGCTACCT 
 
DNMT3a_F  GGCCGAATTGTGTCTTGGTG 
DNMT3a_R  CCATCTCCGAACCACATGAC 
 
DNMT3b_F  CTGTCCGAACCCGACATAGC 
DNMT3bb_R  CCGGAAACTCCACAGGGTA 
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qPCR primers for analysis of regeneration associated genes 
 
Smad1_F  ACTGGCGCAGTCTGTGAAC  
Smad1_R   GGTATTCGGCTCCCCAAC  
 
Stat3_F   CTGAGCCCTCAGCAGGAG  
Stat3_R   AGGTAGCACACTCCGAGGTC  
 
EGR1_F   GAGCGAACAACCCTATGAGC  
EGR1_R   AGGCCACTGACTAGGCTGAA  
 
ATF3_F   AATTGCTGCTGCCAAGTGTC  
ATF3_R   CTTCAGCTCAGCATTCACACTC
79  
TABLE 2: Primers for enzyme-based methylation Q-PCR 
 
ATF3_DE1_F  ACAACGAGAAGCCAGCATAG  
ATF3_DE1_R   AAGGTACCATCCCCAGTCAG  
 
ATF3_DE2_F   GTCCTTCCCTGTTGATCCAG  
ATF3_DE2_R   GAAAGAGAGCCCAGATCCAG  
 
ATF3_DE3_F   TCTGCATTGGCTCCTTACAC  
ATF3_DE3_R   TGACTCAGGTGGAACACTGG  
 
ATF3_DE4_F   TGGTTGTACCCTGTCCTTCC  
ATF3_DE4_R   TGGAGAAGTTGGGGTGTCTG  
 
ATF3_4141_F   GGCGGTGCCTTTATGACTTA  
ATF3_4141_R   TGAGATGAGGTCAGGGAAGC 
 
ATF3_PE1_F   TTGCCACTGTTATCCAGCAC  
ATF3_PE1_R   AGTGACAGCTGCAACAGGAG  
 
ATF3_PE2_F   GTCAAGACCCCTGCACAGAC  
ATF3_PE2_R   CGATCCCTTCCACATTCCTC  
 
ATF3_PE3-4_F   TCCTTTGGTACATGCCTCAG  
ATF3_PE3-4_R   GTTCTGGGGTTTTTCTCCAG  
 
ATF3_GB6_F   CTAGAATCCCAGCAGCCAAG  
ATF3_GB6_R   GGCCAGCTAGGTCATCTGAG  
 
ATF3_GB7_F   CAGAGCCTGGTGTTGTGCTA  
ATF3_GB7_R   GGTGTCGTCCATCCTCTGTT  
 
ATF3_1530_F   CTGCCTTGGACTTGAGGAAC  
ATF3_1530_R   TACGGTCCTGAGGAAAGGTC  
 
ATF3_1423_F   CTTGATTTTGCCCGAAATGT  
ATF3_1423_R   GCTGCCTCCATAGCACCTAC  
 
ATF3_1143_F   CAGACCCTCGGAATTACTGG  
ATF3_1143_R   CACCGAGCCCTCTTGTACTC  
 
Myc_dCG2_F   TGTGGCTTTCCTGTCCTTTT  
Myc_dCG2_R   TAGCGGAATAGCCTGTGGTT  
 
Myc_dCG3_F   GCTGGTGGCTACAAAGGAGA  
Myc_dCG3_R   CCAAGAACCTACATTGCCTGT
80  
 
TABLE 3: Primers for bisulfite sequencing 
 
ATF3 BS_DE1_F   GATTAATAGGGAAGGATTAGGGTAAG  
ATF3 BS_DE1_R   AAACCAACCTAAATAAATTCCAAAC  
 
ATF3 BS_DE2_F   CCTAAAATACAAAAACCTAAATCAAC  
ATF3 BS_DE2_R   GTTTATTAGAAAGTGGGATAGTATAAGTG  
 
NPY BS_F    AGGAAGGTTTTATTAGTAGA 
NPY BS_R    AAA AAAACCTACAACCTCCA  
 
GAP43_BS_F   GTGTGTAGTTAGGTTATATA  
GAP43_BS_R   CTCATAAATATTTAAACACCTCC  
 
Myc_BS_F    GATGTTATTAGGTTGGGGTATAGT  
Myc_BS_R    ACAATAAATAAAACTAACCCTCAAAAAATC
81  
TABLE 4: Primers for ChIP-qPCR 
 
GAP43_CHIP_F   TGAACCTCCATGATTATCAACTG  
GAP43_CHIP_R   CTTTCCCAGTACCACAAGAAGG  
 
ATF3_CHIP_DE1_F  ACAACGAGAAGCCAGCATAG  
ATF3_CHIP_DE1_R  AAGGTACCATCCCCAGTCAG  
 
ATF3_CHIP_DE2_F  GTCCTTCCCTGTTGATCCAG  
ATF3_CHIP_DE2_R  GAAAGAGAGCCCAGATCCAG  
 
ATF3_CHIP_DE3_F  TCTGCATTGGCTCCTTACAC  
ATF3_CHIP_DE3_R  TGACTCAGGTGGAACACTGG  
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